Diagnosis and treatment of acanthosis nigricans

SKINmed

Volumn 8, Issue 3, 2010, Pages 161-164

  Kapoor, Shailendra ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CALCITRIOL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; RETINOIC ACID;

ACANTHOSIS NIGRICANS; AXILLA; DIABETES MELLITUS; FIBROBLAST; HUMAN; INTRADERMAL DRUG ADMINISTRATION; KERATINOCYTE; METABOLISM; NECK; OBESITY; PATHOPHYSIOLOGY; REVIEW;

ACANTHOSIS NIGRICANS; ADMINISTRATION, CUTANEOUS; AXILLA; CALCITRIOL; DERMATOLOGIC AGENTS; DIABETES MELLITUS; FIBROBLASTS; HUMANS; KERATINOCYTES; NECK; OBESITY; TRETINOIN;

EID: 79952114956     PISSN: 15409740     EISSN: 17517125     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Litonjua P, Pinero-Pilona A, Aviles-Santa L, et al. Prevalence of acanthosis nigricans in newly-diagnosed type 2 diabetes. Endocr Pract. 2004;10:101-106.
2. Miura N, Ikezaki A, Iwama S, et al. Genetic factors and clinical significance of acanthosis nigricans in obese Japanese children and adolescents. Acta Paediatr. 2006;95:170-175.
3. Yoshino N, Yamagishi S, Kubokura H, et al. Mediastinal lymph node metastasis of lung cancer with an unknown primary lesion having concurrent endocrine abnormality and acanthosis nigricans: report of a case. Ann Thorac Cardiovasc Surg. 2009;15:397-400.
4. Brantsch KD, Moehrle M. Acanthosis nigricans in a patient with sarcoma of unknown origin. J Am Acad Dermatol. 2010;62:527-528.
5. Ziadi T, Alahyane A, El Fahssi M, et al. Adenocarcinoma of gallbladder revealed by acanthosis nigricans. Gastroenterol Clin Biol. 2009;33:986-988.
6. Mignogna MD, Fortuna G, Falleti J, et al. Gastric diffuse large Bcell lymphoma (DLBCL) exhibiting oral acanthosis nigricans and tripe palms. Dig Liver Dis. 2009;41:766-768.
7. Rosenbach A, Ram R. Treatment of acanthosis nigricans of the axillae using a long-pulsed (5-msec) alexandrite laser. Dermatol Surg. 2004;30:1158-1160.
8. Marshall JD, Bronson RT, Collin GB, et al. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005;165:675-683.
9. Prasad AN. Berardinelli seip syndrome. Indian Pediatr. 2005;42:1245.
10. Rego AG, Mesquita ET, Faria CA, et al. Cardiometabolic abnormalities in patients with berardinelli-Seip syndrome [in Portuguese]. Arq Bras Cardiol. 2010;94:109-118.
11. Sharda S, Panigrahi I, Gupta K, et al. A newborn with acanthosis nigricans: can it be Crouzon syndrome with acanthosis nigricans? Pediatr Dermatol. 2010;27:43-47.
12. Gupta AK, Koley S, Choudhary S, et al. A rare association of acanthosis nigricans with Crouzon syndrome. Indian J Dermatol Venereol Leprol. 2010;76:65-67.
13. Miranda DM, Wajchenberg BL, Calsolari MR, et al. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol (Oxf). 2009;71:512-517.
14. Downs AM, Kennedy CT. Somatotrophin-induced acanthosis nigricans. Br J Dermatol. 1999;141:390-391.
15. Ben-Shlomo A, Melmed S. Skin manifestations in acromegaly. Clin Dermatol. 2006;24:256-259.
16. Uwaifo GI, Tjahjana M, Freedman RJ, et al. Acanthosis nigricans in patients with nonalcoholic steatohepatitis: an uncommon finding. Endocr Pract. 2006;12:371-379.
17. Kroumpouzos G, Avgerinou G, Granter SR. Acanthosis nigricans without diabetes during pregnancy. Br J Dermatol. 2002;146:925-928.
18. Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5:199-203.
19. Hida Y, Kubo Y, Nishio Y, et al. Malignant acanthosis nigricans with enhanced expression of fibroblast growth factor receptor 3. Acta Derm Venereol. 2009;89:435-437.
20. Tabandeh H, Gopal S, Teimory M, et al. Conjunctival involvement in malignancy-associated acanthosis nigricans. Eye. 1993;7(pt 5):648-651.
21. Cannavo SP, Guarneri C, Borgia F, et al. Confluent and reticulated papillomatosis and acanthosis nigricans in an obese girl: two distinct pathologies with a common pathogenetic pathway or a unique entity dependent on insulin resistance? J Eur Acad Dermatol Venereol. 2006;20:478-480.
22. Kim SK, Kim YC. Nevoid acanthosis nigricans localized to the umbilicus. J Dermatol. 2006;33:433-434.
23. Ogbera AO, Akinlade A, Ajose O, et al. Prevalence of acanthosis nigricans and its correlates in a cross-section of Nigerians with type 2 diabetes mellitus. Trop Doct. 2009;39:235-236.
24. Takahashi I, Yamada Y, Kadowaki H, et al. Phenotypical variety of insulin resistance in a family with a novel mutation of the insulin receptor gene. Endocr J. 2010 Mar 25. [Epub ahead of print]
25. Scott AT, Metzig AM, Hames RK, et al. Acanthosis nigricans and oral glucose tolerance in obese children. Clin Pediatr (Phila). 2010;49:69-71.
26. Mukhtar Q, Cleverley G, Voorhees RE, et al. Prevalence of acanthosis nigricans and its association with hyperinsulinemia in New Mexico adolescents. J Adolesc Health. 2001;28:372-376.
27. Kong AS, Williams RL, Smith M, et al. Acanthosis nigricans and diabetes risk factors: prevalence in young persons seen in southwestern US primary care practices. Ann Fam Med. 2007;5:202-208.
28. Nair PS, Moorthy PK, Suprakasan S, et al. Malignant acanthosis nigricans with liver secondaries from an occult primary adenocarcinoma of gastrointestinal tract. Indian J Dermatol Venereol Leprol. 2005;71:197-198.
29. Pentenero M, Carrozzo M, Pagano M, et al. Oral acanthosis nigricans, tripe palms and sign of leser-trélat in a patient with gastric adenocarcinoma. Int J Dermatol. 2004;43:530-532.
30. Tao YC, Slavotinek A, Vargervik K, et al. Hypodontia in Beare-Stevenson syndrome: an example of dental anomalies in FGFRrelated craniosynostosis syndromes. Cleft Palate Craniofac J. 2010;47:253-258.
31. Galli-Tsinopoulou A, Grammatikopoulou M, Stylianou C, et al. Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese. J Endocrinol Invest. 2010 Feb 24. [Epub ahead of print]
32. Brickman WJ, Huang J, Silverman BL, et al. Acanthosis nigricans identifies youth at high risk for metabolic abnormalities. J Pediatr. 2010;156:87-92.
33. Felszeghy E, Kaposzta R, Juhasz E, et al. Alterations of carbohydrate and lipoprotein metabolism in childhood obesity--impact of insulin resistance and acanthosis nigricans. J Pediatr Endocrinol Metab. 2009;22:1117-1126.
34. Charnvises K, Weerakiet S, Tingthanatikul Y, et al. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome. Gynecol Endocrinol. 2005;21:161-164.
35. Alemzadeh R, Kichler J, Calhoun M. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome. Eur J Endocrinol. Apr 6. [Epub ahead of print]
36. El Safoury O, Rashid L, Ibrahim M. A study of androgen and estrogen receptors alpha, beta in skin tags. Indian J Dermatol. 2010;55:20-24.
37. Fareau GG, Maldonado M, Oral E, et al. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism. 2007;56:670-675.
38. Dash S, Sano H, Rochford JJ, et al. A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia. Proc Natl Acad Sci U S A. 2009;106:9350-9355.
39. Kurtoglu S, Atabek ME, Keskin M, et al. Acanthosis nigricans in association with congenital adrenal hyperplasia: resolution after treatment. case report. Turk J Pediatr. 2005;47:183-187.
40. Eberting CL, Javor E, Gorden P, et al. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia. J Am Acad Dermatol. 2005;52:341-344.
41. Otto DE, Wang X, Tijerina SL, et al. A comparison of blood pressure, body mass index, and acanthosis nigricans in school-age children. J Sch Nurs. 2010 Mar 24. [Epub ahead of print]
42. Wasniewska M, Arrigo T, Crisafulli G, et al. Recovery of acanthosis nigricans under prolonged metformin treatment in an adolescent with normal weight. J Endocrinol Invest. 2009;32:939-940.
43. Srinivasan S, Ambler GR, Baur LA, et al. Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin. J Clin Endocrinol Metab. 2006;91:2074-2080.
44. Bellot-Rojas P, Posadas-Sanchez R, Caracas-Portilla N, et al. Comparison of metformin versus rosiglitazone in patients with acanthosis nigricans: a pilot study. J Drugs Dermatol. 2006;5:884-889.
45. Blobstein SH. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity. Cutis. 2003;71:33-34.
46. Lee HW, Chang SE, Lee MW, et al. Hyperkeratosis of the nipple associated with acanthosis nigricans: treatment with topical calcipotriol. J Am Acad Dermatol. 2005;52:529-530.
47. Walling HW, Messingham M, Myers LM, et al. Improvement of acanthosis nigricans on isotretinoin and metformin. J Drugs Dermatol. 2003;2:677-681.
48. Ozdemir M, Toy H, Mevlitoglu I, et al. Generalized idiopathic acanthosis nigricans treated with acitretin. J Dermatolog Treat. 2006;17:54-56.
49. Schmolke B, Grotmann P, Kreusch J, et al. Surgical therapy of lip involvement in acanthosis nigricans maligna. Hautarzt. 1994;45:875-877.